Literature DB >> 35212621

A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.

Tessa Parkes1, Catriona Matheson1, Hannah Carver1, Rebecca Foster1, John Budd2, Dave Liddell3, Jason Wallace3, Bernie Pauly4, Maria Fotopoulou5, Adam Burley2, Isobel Anderson5, Graeme MacLennan6.   

Abstract

BACKGROUND: For people experiencing homelessness and problem substance use, access to appropriate services can be challenging. There is evidence that development of trusting relationships with non-judgemental staff can facilitate service engagement. Peer-delivered approaches show particular promise, but the evidence base is still developing. This study tested the feasibility and acceptability of a peer-delivered intervention, through 'Peer Navigators', to support people who are homeless with problem substance use to address a range of health and social issues.
OBJECTIVES: The study objectives were to design and implement a peer-delivered, relational intervention to reduce harms and improve health/well-being, quality of life and social functioning for people experiencing homelessness and problem substance use, and to conduct a concurrent process evaluation to inform a future randomised controlled trial.
DESIGN: A mixed-methods feasibility study with concurrent process evaluation was conducted, involving qualitative interviews [staff interviews (one time point), n = 12; Peer Navigator interviews (three or four time points), n = 15; intervention participant interviews: first time point, n = 24, and second time point, n = 10], observations and quantitative outcome measures.
SETTING: The intervention was delivered in three outreach services for people who are homeless in Scotland, and three Salvation Army hostels in England; there were two standard care settings: an outreach service in Scotland and a hostel in England. PARTICIPANTS: Participants were people experiencing homelessness and problem substance use (n = 68) (intervention). INTERVENTION: This was a peer-delivered, relational intervention drawing on principles of psychologically informed environments, with Peer Navigators providing practical and emotional support. MAIN OUTCOME MEASURES: Outcomes relating to participants' substance use, participants' physical and mental health needs, and the quality of Peer Navigator relationships were measured via a 'holistic health check', with six questionnaires completed at two time points: a specially created sociodemographic, health and housing status questionnaire; the Patient Health Questionnaire-9 items plus the Generalised Anxiety Disorder-7; the Maudsley Addiction Profile; the Substance Use Recovery Evaluator; the RAND Corporation Short Form survey-36 items; and the Consultation and Relational Empathy Measure.
RESULTS: The Supporting Harm Reduction through Peer Support (SHARPS) study was found to be acceptable to, and feasible for, intervention participants, staff and Peer Navigators. Among participants, there was reduced drug use and an increase in the number of prescriptions for opioid substitution therapy. There were reductions in risky injecting practice and risky sexual behaviour. Participants reported improvements to service engagement and felt more equipped to access services on their own. The lived experience of the Peer Navigators was highlighted as particularly helpful, enabling the development of trusting, authentic and meaningful relationships. The relationship with the Peer Navigator was measured as excellent at baseline and follow-up. Some challenges were experienced in relation to the 'fit' of the intervention within some settings and will inform future studies. LIMITATIONS: Some participants did not complete the outcome measures, or did not complete both sets, meaning that we do not have baseline and/or follow-up data for all. The standard care data sample sizes make comparison between settings limited.
CONCLUSIONS: A randomised controlled trial is recommended to assess the effectiveness of the Peer Navigator intervention. FUTURE WORK: A definitive cluster randomised controlled trial should particularly consider setting selection, outcomes and quantitative data collection instruments. TRIAL REGISTRATION: This trial is registered as ISRCTN15900054. FUNDING: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 26, No. 14. See the NIHR Journals Library website for further project information.

Entities:  

Keywords:  FEASIBILITY STUDIES; HARM REDUCTION; HOMELESS PERSONS; MENTAL HEALTH; OUTCOME ASSESSMENTS; PATIENT HEALTH QUESTIONNAIRE; PEER GROUP; QUALITY OF LIFE; SUBSTANCE-RELATED DISORDERS

Mesh:

Year:  2022        PMID: 35212621      PMCID: PMC8899911          DOI: 10.3310/WVVL4786

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


  83 in total

1.  Complex interventions: how "out of control" can a randomised controlled trial be?

Authors:  Penelope Hawe; Alan Shiell; Therese Riley
Journal:  BMJ       Date:  2004-06-26

Review 2.  How can health services effectively meet the health needs of homeless people?

Authors:  Nat M J Wright; Charlotte N E Tompkins
Journal:  Br J Gen Pract       Date:  2006-04       Impact factor: 5.386

3.  Community managed alcohol programs in Canada: Overview of key dimensions and implementation.

Authors:  Bernadette Bernie Pauly; Kate Vallance; Ashley Wettlaufer; Clifton Chow; Randi Brown; Joshua Evans; Erin Gray; Bonnie Krysowaty; Andrew Ivsins; Rebecca Schiff; Tim Stockwell
Journal:  Drug Alcohol Rev       Date:  2018-03-24

4.  "People knew they could come here to get help": an ethnographic study of assisted injection practices at a peer-run 'unsanctioned' supervised drug consumption room in a Canadian setting.

Authors:  Ryan McNeil; Will Small; Hugh Lampkin; Kate Shannon; Thomas Kerr
Journal:  AIDS Behav       Date:  2014-03

5.  Normalisation process theory: a framework for developing, evaluating and implementing complex interventions.

Authors:  Elizabeth Murray; Shaun Treweek; Catherine Pope; Anne MacFarlane; Luciana Ballini; Christopher Dowrick; Tracy Finch; Anne Kennedy; Frances Mair; Catherine O'Donnell; Bie Nio Ong; Tim Rapley; Anne Rogers; Carl May
Journal:  BMC Med       Date:  2010-10-20       Impact factor: 8.775

6.  Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study.

Authors:  Robert S Broadhead; Douglas D Heckathorn; Frederick L Altice; Yaël van Hulst; Michael Carbone; Gerald H Friedland; Patrick G O'Connor; Peter A Selwyn
Journal:  Soc Sci Med       Date:  2002-07       Impact factor: 4.634

7.  Expert viewpoints of peer support for people experiencing homelessness: A Q sort study.

Authors:  Stephanie L Barker; Nick Maguire; Felicity L Bishop; Lusia L Stopa
Journal:  Psychol Serv       Date:  2018-11-01

8.  Using peer advocates to improve access to services among hard-to-reach populations with hepatitis C: a qualitative study of client and provider relationships.

Authors:  Jennifer MacLellan; Julian Surey; Ibrahim Abubakar; Helen R Stagg; Jenevieve Mannell
Journal:  Harm Reduct J       Date:  2017-11-28

9.  Supporting Harm Reduction through Peer Support (SHARPS): testing the feasibility and acceptability of a peer-delivered, relational intervention for people with problem substance use who are homeless, to improve health outcomes, quality of life and social functioning and reduce harms: study protocol.

Authors:  Tessa Parkes; Catriona Matheson; Hannah Carver; John Budd; Dave Liddell; Jason Wallace; Bernie Pauly; Maria Fotopoulou; Adam Burley; Isobel Anderson; Graeme MacLennan; Rebecca Foster
Journal:  Pilot Feasibility Stud       Date:  2019-04-29

10.  DEVELOPMENT AND VALIDATION OF 'SURE': A PATIENT REPORTED OUTCOME MEASURE (PROM) FOR RECOVERY FROM DRUG AND ALCOHOL DEPENDENCE.

Authors:  Joanne Neale; Silia Vitoratou; Emily Finch; Paul Lennon; Luke Mitcheson; Daria Panebianco; Diana Rose; John Strang; Til Wykes; John Marsden
Journal:  Drug Alcohol Depend       Date:  2016-06-15       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.